Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

1–25 of 38 articles for Cabergoline

Then save them, add them to a collection or cite them together.
  1. Conference abstract · 30 Oct 2017

    Different cabergoline effect on visceral adiposity index (VAI) in female prolactinoma patients versus idiopathic hyperprolactinemia patients

    Endocrinology & Metabolic Syndrome

    prolactinoma versus newly diagnosed female patients with idiopathic hyperprolactinemia, and to assess one year-Cabergoline therapy effects on these parameters in both groups by using visceral adiposity index ... Waist…

  2. Case report · 2014

    Letrozole and Cabergoline Co-administration in the Early Luteal Phase for Prevention of OHSS in a High Risk Patient Undergoing Ovarian Stimulation for IVF

    Journal of Fertilization: In Vitro - IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biol · Volume 2, Issue 4

    embryo transfer, daily 5 mg Letrozole and 0.5 mg Cabergoline. One embryo was transferred on day 5 post oocyte retrieval.The patient did not develop any early nor late OHSS while ... succesful ongoing pregnancy was…

  3. Conference abstract · 31 Mar 2020

    Efficacy of Letrozole (LE) Combined with Cabergoline (CE) in Comparison to LE alone in ovulation induction among patients with Polycystic Ovarian Syndrome (PCOS) and Hyperprolactinemia (HP)

    Insights in Reproductive Medicine · Volume 4, Issue 1

    Efficacy of Letrozole (LE) Combined with Cabergoline (CE) in Comparison to LE alone in ovulation induction among patients with Polycystic Ovarian Syndrome (PCOS) and Hyperprolactinemia (HP) Aisha Elbareg Associate…

  4. Research article · 15 Jan 2017

    Acromegaly: casuistry of therapeutic success clinical and surgical

    Biomedical Research · Volume 28, Issue 1

    Patients with DC that used Sandostatin were 80%, being that 55% cabergoline associated, 10% only cabergoline, 10% had no surgery. 30% suspended medications due to successful therapeutics. Conclusion: Our study

  5. Review article · 28 Jul 2020

    Toxicology-2020: Pituitary-Directed Drug Therapy for the Treatment of Cushing's disease: A Review Article- Michael Crider Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, USA

    Medical Toxicology: Current Research · Volume 3, Issue 1

    peroxisome proliferator-activated gamma (PPARγ) agonists rosiglitazone and pioglitazone, the dopamine D2 agonist cabergoline, and the somatostatin peptidomimetic pasireotide. PPARγ agonists such as rosiglitazone and…

  6. Article · 8 Sep 2022

    Treatment of Prolactinoma

    Journal of Health and Medical Research · Volume 7, Issue 1

    have been the cornerstone of prolactinoma therapy, first with bromocriptine and more recently with cabergoline. In up to 85% of patients, cabergoline normalizes prolactin ... cases, it shrinks tumors. Similar to…

  7. Editorial · 17 Dec 2018

    Cardiology-2020: Peripartum Cardiomyopathy: Four Case Reports with Different Outcomes - Issues with Management- Marzia Cottini- Cardiac Surgery Unit, San Camillo Hospital, Rome, Italy

    Journal of Cholesterol and Heart Disease · Volume 2, Issue 3

    early timing postpartum (just one day), a dopamine D2 receptor agonist was promptly administrated (cabergoline 1 mg, single dose). Finally, the patient underwent also an endomyocardial biopsy in order ... plasma level…

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels